|
ZNF641 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.751800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.515440E-01 |
| Normal-vs-Stage2 |
3.158800E-01 |
| Normal-vs-Stage3 |
1.976420E-02 |
| Normal-vs-Stage4 |
4.204500E-04 |
| Stage1-vs-Stage2 |
7.824100E-02 |
| Stage1-vs-Stage3 |
9.218500E-04 |
| Stage1-vs-Stage4 |
2.48840000000028E-05 |
| Stage2-vs-Stage3 |
4.944800E-01 |
| Stage2-vs-Stage4 |
9.527900E-02 |
| Stage3-vs-Stage4 |
2.457800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.081200E-01 |
| Normal-vs-AfricanAmerican |
1.690210E-02 |
| Normal-vs-Asian |
4.123400E-01 |
| Caucasian-vs-AfricanAmerican |
4.049800E-02 |
| Caucasian-vs-Asian |
1.824600E-01 |
| AfricanAmerican-vs-Asian |
5.375900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.052300E-02 |
| Normal-vs-Female |
7.330400E-01 |
| Male-vs-Female |
6.529700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.287800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.788400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.407640E-01 |
| Normal-vs-Age(81-100Yrs) |
4.243400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.679400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.845000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.140400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.833770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.499800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.288200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.406000E-02 |
| Normal-vs-Grade 2 |
1.503850E-01 |
| Normal-vs-Grade 3 |
3.053500E-02 |
| Normal-vs-Grade 4 |
1.90083999999091E-05 |
| Grade 1-vs-Grade 2 |
1.548220E-01 |
| Grade 1-vs-Grade 3 |
3.882700E-03 |
| Grade 1-vs-Grade 4 |
6.20259999999373E-05 |
| Grade 2-vs-Grade 3 |
1.024150E-03 |
| Grade 2-vs-Grade 4 |
2.51100000014937E-07 |
| Grade 3-vs-Grade 4 |
7.041300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.661600E-03 |
| Normal-vs-ccB subtype |
1.304250E-02 |
| ccA subtype-vs-ccB subtype |
9.91539999994906E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.684000E-01 |
| Normal-vs-N1 |
1.036810E-01 |
| N0-vs-N1 |
8.799600E-02 |
|
|
